Results 131 to 140 of about 600,282 (299)
Medical Device Recalls in Neurosurgery: A United States Regulatory Analysis. [PDF]
Bhenderu LS +9 more
europepmc +1 more source
Brain organoids are emerging as increasingly functional human‐relevant platforms, yet limitations in vascularization, maturation, measurement, and reproducibility still constrain their translational value. This Perspective examines how microfluidics, biofabrication, advanced imaging, electrophysiology, multimodal AI, standardization, and ethical ...
Aishwarya Pantula +4 more
wiley +1 more source
In this update, we review the US FDA’s updated compendium of real-world evidence (RWE) use in medical device regulatory decisions, a comprehensive scan of RWE utilization in Canadian drug reimbursement submissions, and Institute for Clinical and ...
Paul Arora, Sreeram V Ramagopalan
doaj +1 more source
The US Food and Drug Administration's TEMPO Pilot Signals a New Regulatory Approach for AI-Enabled Medical Devices. [PDF]
Athni TS.
europepmc +1 more source
Smart Nanotechnologies for Multimodal Neuromodulation and Brain Interfacing
Recent advances in smart nanotechnologies are expanding the toolbox for brain interfacing, from wireless neuromodulation and high‐resolution sensing to targeted delivery within the central nervous system. By combining responsive nanomaterials with bioinspired design, these platforms enable multimodal interactions with neurons and glia, while also ...
Tommaso Curiale +6 more
wiley +1 more source
Model Master File Framework: A Regulatory Path Advancing Modeling and Simulation Applications. [PDF]
Tsakalozou E +4 more
europepmc +1 more source
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib +8 more
wiley +1 more source
A Practical Guide to Implementing Real-World Evidence as Primary Basis for Approval and Label Expansion. [PDF]
Mayne TJ, Brookhart MA, Dreyer NA.
europepmc +1 more source

